Essa Pharma is a clinical-stage biopharmaceutical company focused on developing innovative therapies for the treatment of cancer

With a commitment to advancing targeted treatments, the company primarily works on potent small molecule inhibitors designed to selectively target and inhibit the activity of specific proteins involved in cancer cell growth and survival. Essa Pharma aims to address significant unmet needs in oncology, particularly in the treatment of prostate cancer, by leveraging its expertise in medicinal chemistry and drug development to bring new options to patients. Through its research and development initiatives, the company strives to enhance patient outcomes and improve the quality of life for those affected by cancer.